Article Data

  • Views 554
  • Dowloads 127

Original Research

Open Access

Correlation between the body mass index of patients with breast cancer before and after chemotherapy

  • A. Pratti Lucarelli1,*,
  • M.M. Martins1
  • J.M. Guedes1

1Mastology Unit of the Gynecology and Obstetrics Department of the Irmandade da Santa Casa de Misericórdia de São Paulo/Santa Casa De São Paulo - Faculty of Medical Sciences, São Paulo, Brazil

DOI: 10.12892/ejgo3741.2017 Vol.38,Issue 2,April 2017 pp.187-190

Published: 10 April 2017

*Corresponding Author(s): A. Pratti Lucarelli E-mail: adrilucarelli@terra.com.br

Abstract

The objective of this work was to show how the influence of the microenvironment in tumor cells and consequently the onset and tumor progression is becoming increasingly more evident. Cancer is the second leading cause of death in the developed world, surpassed only by heart disease and obesity, and is increasingly recognised as an oncogenic factor in the genesis of this tumor. Inflammatory mediators related to obesity are suspected to play a role in oncogenic modification of substrates metabolism of nutrients, most patients diagnosed with breast cancer underwent chemotherapy treatment, and this may be an aggravating factor of obesity. The authors selected 49 patients with previous diagnosis of breast cancer who had undergone chemotherapy and evaluated data regarding body mass index (BMI) before and after chemotherapy. They observed that there was statistical difference of BMI of patients before and after chemotherapy with p = 0.03. Comparing the groups, a statistical difference was found between overweight and obesity grade II and overweight and obesity grade III. Patients with a diagnosis of breast cancer usually showed on average a BMI 27.84, worsening after chemotherapy to 28.64. These findings can help to accelerate the division and cell reproduction, because obesity is a risk factor for breast cancer, and weight gain seems to be a major factor after treatment and may influence the prognosis of these women.

Keywords

Breast cancer; Body mass index; Chemotherapy; Body weight.

Cite and Share

A. Pratti Lucarelli,M.M. Martins,J.M. Guedes. Correlation between the body mass index of patients with breast cancer before and after chemotherapy. European Journal of Gynaecological Oncology. 2017. 38(2);187-190.

References

[1] World Healthy Organization (WHO): “Obesity”. Available at: http//www.who.int/mediacentre/factsheets>2014

[2] Sundaram S., Johnson A.R., Makowski L.: “Obesity, metabolism and the microenvironment: links to cancer”. J. Carcinog., 2013, 12, 19

[3] Bliss J.M., Gray R.: “Breast cancer and hormone-replacement therapy: The Million Women Study”. Lancet, 2003, 362, 1328.

[4] Laurent V., Nieto L., Valet P., Muller C.: “Adipose tissue and cancer: a high risk tandem”. Med. Sci. (Paris), 2014, 30, 398.

[5] Marsden J., A’Hern R.: “The Million Women Study and breast cancer”. J. Br. Menopause Soc., 2003, 9, 95.

[6] Beral V., Million Women Study Collaborators: “Breast cancer and hormone- replacement therapy in the million women study”. Lancet, 2003, 362, 419.

[7] Madarnas Y., Sawka C.A., Franssen E., Bjarnason G.A.: “Are medical oncologists biased in their treatment of the large woman with breast cancer?” Breast Cancer Res. Treat., 2001, 66, 123.

[8] Millikan R.C., Newman B., Tse C.K., Moorman P.G., Conway K., Dressler L.G., et al.: “Epidemiology of basal-like breast cancer”. Breast Cancer Res. Treat., 2008, 109, 123.

[9] Baker S.D., Grochow L.B., Donehower R.C.: “Should anticancer drug doses be adjusted in the obese patient?” J. Natl. Cancer Inst., 1995, 87, 333.

[10] Protani M., Coory M., Martin J.H.: “Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis”. Breast Cancer Res. Treat., 2010, 123, 627.

[11] Portugal R.D.: “Obesity and dose individualization in cancer hemotherapy: The role of body surface area body mass index”. Med. Hypotheses, 2005, 65, 748.

[12] Poikonen P., Blomqvist C., Joensuu H.: “Effects of obesity onthe leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area”. Acta Oncol., 2001, 40, 67.

[13] Rosner G.L., Hargis J.H., Hollis D.R., Budman D.R., Weiss R.B., Henderson I.C., et al.: “Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541”. J. Clin. Oncol., 1996, 14, 3000.

[14] Bastarrachea J., Hortobagyi G.N., Smith T.L., Kau S.W.C., Buzdar A.U.: “Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer”. Am. Coll. Physicians, 1993, 119, 18.

[15] Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M.: “Bodymass index and incidence of cancer: a systematic review and metaanalysis of prospective observational studies”. Lancet, 2008, 371, 569.

[16] Sasa M., Bando Y., Takahashi M., Hirose T., Nagao T.: “Screening for basal marker expression is necessary for decision of therapeutic strategy for triple-negative breast cancer”. J. Surg. Oncol., 2008, 97, 30.

[17] Connolly B.S., Barnett C., Vogt K.N., Li T., Stone J., Boyd N.F.: “A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer”. Nutr. Cancer, 2002, 44, 127.

[18] Harvie M., Hooper L., Howell A.H.: “Central obesity and breast cancer risk: a systematic review”. Obes. Rev., 2003, 4, 157.

[19] Millikan R.C., Newman B., Tse C.K., Moorman P.G., Conway K., Dressler L.G., et al.: “Epidemiology of basal-like breast cancer”. Breast Cancer Res. Treat., 2008, 109, 123. Epub 2007 Jun 20.

[20] Basen-Engquist K., Chang M.: “Obesity and cancer risk: recent review and evidence”. Curr. Oncol. Rep., 2011, 13, 71.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top